Legal & General Group’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $10.5K | Hold |
|
|||||
|
2024
Q4 | $14.3K | Hold |
|
|||||
|
2024
Q3 | $20K | Hold |
|
|||||
|
2024
Q2 | $18.9K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $288K | Sell |
|
|||||
|
2022
Q4 | $1.22M | Buy |
|
|||||
|
2022
Q3 | $1.69M | Sell |
|
|||||
|
2022
Q2 | $2.36M | Buy |
|
|||||
|
2022
Q1 | $3.34M | Buy |
|
|||||
|
2021
Q4 | $6.95M | Buy |
|
|||||
|
2021
Q3 | $4.5M | Buy |
|
|||||
|
2021
Q2 | $3.72M | Sell |
|
|||||
|
2021
Q1 | $5.29M | Sell |
|
|||||
|
2020
Q4 | $5.14M | Sell |
|
|||||
|
2020
Q3 | $5.4M | Buy |
|
|||||
|
2020
Q2 | $7.07M | Sell |
|
|||||
|
2020
Q1 | $5.93M | Buy |
|
|||||
|
2019
Q4 | $6.61M | Sell |
|
|||||
|
2019
Q3 | $12.5M | Buy |
|
|||||
|
2019
Q2 | $23.8M | Buy |
|
|||||
|
2019
Q1 | $20.8M | Buy |
|
|||||
|
2018
Q4 | $13.4M | Buy |
|
|||||
|
2018
Q3 | $21.3M | Buy |
|
|||||
|
2018
Q2 | $14.8M | Buy |
|
|||||
|
2018
Q1 | $16.1M | Sell |
|
|||||
|
2017
Q4 | $18.8M | Buy |
|
|||||
|
2017
Q3 | $7.35M | Buy |
|
|||||
|
2017
Q2 | $5.77M | Buy |
|
|||||
|
2017
Q1 | $6.3M | Buy |
|
|||||
|
2016
Q4 | $3.24M | Buy |
|
|||||
|
2016
Q3 | $2.17M | Buy |
|
|||||
|
2016
Q2 | $472K | Buy |
|
|||||
|
2016
Q1 | $404K | Buy |
|
|||||
|
2015
Q4 | $473K | Hold |
|
|||||
|
2015
Q3 | $300K | Buy |
|
|||||
|
2015
Q2 | $297K | Buy |
|
|||||
|
2015
Q1 | $251K | Buy |
|
|||||
|
2014
Q4 | $296K | Sell |
|
|||||
|
2014
Q3 | $245K | Buy |
|